The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Akero Therapeutics Inc | COM | 00973Y108 | 39,151,716 | 1,676,733 | SH | OTR | 1,676,733 | 0 | 0 | ||
AnaptysBio Inc | COM | 032724106 | 27,846,000 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
Apellis Pharmaceuticals Inc | COM | 03753U106 | 103,318,360 | 1,726,000 | SH | OTR | 1,726,000 | 0 | 0 | ||
Arcus Biosciences Inc | COM | 03969F109 | 30,602,020 | 1,602,200 | SH | OTR | 1,602,200 | 0 | 0 | ||
Argenx SE | SPONSORED ADR | 04016X101 | 60,868,800 | 160,000 | SH | OTR | 160,000 | 0 | 0 | ||
Arvinas Inc | COM | 04335A105 | 25,050,552 | 608,614 | SH | OTR | 608,614 | 0 | 0 | ||
Atreca Inc | CL A COM | 04965G109 | 290,708 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | ||
Avidity Biosciences Inc | COM | 05370A108 | 10,148,009 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | ||
Axsome Therapeutics Inc | COM | 05464T104 | 31,836,000 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
BeiGene Ltd | SPONSORED ADR | 07725L102 | 90,180,000 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
BioAtla Inc | COM | 09077B104 | 1,688,414 | 686,347 | SH | OTR | 686,347 | 0 | 0 | ||
Black Diamond Therapeutics I | COM | 09203E105 | 1,421,860 | 506,000 | SH | OTR | 506,000 | 0 | 0 | ||
Cytokinetics Inc | COM NEW | 23282W605 | 175,329,000 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
Day One Biopharmaceuticals I | COM | 23954D109 | 17,373,168 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | ||
DBV Technologies S A | SPONSORED ADR | 23306J101 | 476,400 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
Enliven Therapeutics Inc | COM | 29337E102 | 8,941,443 | 646,058 | SH | OTR | 646,058 | 0 | 0 | ||
Fate Therapeutics Inc | COM | 31189P102 | 1,870,000 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
Geron Corp | COM | 374163103 | 6,330,000 | 3,000,000 | SH | OTR | 3,000,000 | 0 | 0 | ||
Structure Therapeutics Inc | SPONSORED ADS | 86366E106 | 16,304,000 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
Ideaya Biosciences Inc | COM | 45166A102 | 78,376,051 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
ImmunoGen Inc | COM | 45253H101 | 87,793,650 | 2,961,000 | SH | OTR | 2,961,000 | 0 | 0 | ||
Immunovant Inc | COM | 45258J102 | 42,130,000 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
Iovance Biotherapeutics Inc | COM | 462260100 | 11,382,000 | 1,400,000 | SH | OTR | 1,400,000 | 0 | 0 | ||
iTeos Therapeutics Inc | COM | 46565G104 | 19,754,435 | 1,804,058 | SH | OTR | 1,804,058 | 0 | 0 | ||
Kalvista Pharmaceuticals Inc | COM | 483497103 | 20,212,500 | 1,650,000 | SH | OTR | 1,650,000 | 0 | 0 | ||
Karuna Therapeutics Inc | COM | 48576A100 | 79,127,500 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
Kodiak Sciences Inc | COM | 50015M109 | 1,824,000 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
Legend Biotech Corp | SPONSORED ADS | 52490G102 | 36,102,000 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
Merus N V | COM | N5749R100 | 52,250,000 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
Milestone Pharmaceuticals In | COM | 59935V107 | 516,042 | 309,007 | SH | OTR | 309,007 | 0 | 0 | ||
Mirati Therapeutics Inc | COM | 60468T105 | 188,084,600 | 3,201,440 | SH | OTR | 3,201,440 | 0 | 0 | ||
Nkarta Inc | COM | 65487U108 | 9,504,000 | 1,440,000 | SH | OTR | 1,440,000 | 0 | 0 | ||
Nuvalent Inc | COM | 670703107 | 82,434,929 | 1,120,192 | SH | OTR | 1,120,192 | 0 | 0 | ||
Nuvation Bio Inc | *W EXP 07/07/202 | 67080N119 | 16,000 | 266,666 | SH | OTR | 266,666 | 0 | 0 | ||
Oric Pharmaceuticals Inc | COM | 68622P109 | 15,939,653 | 1,732,571 | SH | OTR | 1,732,571 | 0 | 0 | ||
Orchestra Biomed Hldgs Inc | COM | 68572M106 | 2,174,702 | 238,193 | SH | OTR | 238,193 | 0 | 0 | ||
Prelude Therapeutics Inc | COM | 74065P101 | 10,966,585 | 2,568,287 | SH | OTR | 2,568,287 | 0 | 0 | ||
Protara Therapeutics Inc | COM STK | 74365U107 | 392,322 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
Prothena Corp PLC | SHS | G72800108 | 24,166,100 | 665,000 | SH | OTR | 665,000 | 0 | 0 | ||
Rain Oncology Inc | COM | 75082Q105 | 1,382,654 | 1,152,212 | SH | OTR | 1,152,212 | 0 | 0 | ||
Relay Therapeutics Inc | COM | 75943R102 | 20,028,643 | 1,819,132 | SH | OTR | 1,819,132 | 0 | 0 | ||
Revolution Medicines Inc | COM | 76155X100 | 122,735,028 | 4,279,464 | SH | OTR | 4,279,464 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | COM | 77313F106 | 43,937,548 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
Sarepta Therapeutics Inc | COM | 803607100 | 62,679,500 | 650,000 | SH | OTR | 650,000 | 0 | 0 | ||
Springworks Therapeutics Inc | COM | 85205L107 | 124,886,247 | 3,421,541 | SH | OTR | 3,421,541 | 0 | 0 | ||
Spyre Therapeutics Inc | COM NEW | 00773J202 | 5,380,000 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
Surrozen Inc | *W EXP 08/01/203 | 86889P117 | 1,333 | 66,666 | SH | OTR | 66,666 | 0 | 0 | ||
Tango Therapeutics Inc | COM | 87583X109 | 81,166,556 | 8,198,642 | SH | OTR | 8,198,642 | 0 | 0 | ||
Third Harmonic Bio Inc | COM | 88427A107 | 8,227,500 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
Tyra Biosciences Inc | COM | 90240B106 | 89,309,772 | 6,448,359 | SH | OTR | 6,448,359 | 0 | 0 | ||
Xenon Pharmaceuticals Inc | COM | 98420N105 | 27,636,000 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
Zentalis Pharmaceuticals Inc | COM | 98943L107 | 6,817,500 | 450,000 | SH | OTR | 450,000 | 0 | 0 |